Proteogenomic Subtyping of Chronic Lymphocytic Leukemia Identifies a Novel Poor Outcome Subgroup with a Distinct Drug Response Profile

JSON

Herbst SA, Vesterlund M, Jafari R, Siavelis I, Stahl M, Schitter E, Helmboldt AJ, Iskar M, Liebers N, Czernilofsky F, Roider T, Bruch PM, Lu J, Richter S, Mermelekas G, Umer HM, Knoll M, Kolb C, Lenze A, Cao X, Österholm-Corbascio C, Scheinost S, Ganzinger M, Mansouri L, Kriegsmann K, Kriegsmann M, Mueller-Tidow C, Dreger P, Anders S, Zapatka M, Herling M, Rosenquist R, Stilgenbauer S, Zenz T, Huber W, Tausch E, Lehtiö J, Dietrich S

Blood 136 (Supplement 1) 10-11 [2020-11-05; online 2020-11-05]

DOI 10.1182/blood-2020-137528

Crossref 10.1182/blood-2020-137528